The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer
about
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy.Optimizing the management of HER2-positive early breast cancer: the clinical reality.Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.Personalized medicine policy challenges: measuring clinical utility at point of care.Design and evaluation of radiolabeled tracers for tumor imaging.Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas.
P2860
The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@ast
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@en
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@nl
type
label
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@ast
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@en
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@nl
prefLabel
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@ast
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@en
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@nl
P2093
P2860
P356
P1433
P1476
The role of HER2-targeted ther ...... ssing metastatic breast cancer
@en
P2093
J Latreille
K Pritchard
L Provencher
P2860
P356
10.3747/CO.V16I4.469
P407
P577
2009-08-01T00:00:00Z